Axion BioSystems and Agilent Technologies Resolve Litigation

ATLANTA--(BUSINESS WIRE)--Axion BioSystems, Inc., a leading provider of live-cell analysis technologies, today announced that Agilent Technologies, Inc. and Axion BioSystems have fully resolved the issues in the two lawsuits between them, pending in the United States District Court for the District of Delaware, pursuant to the terms of a confidential settlement agreement. Neither party has admitted liability for the other party's claims or counterclaims or otherwise agreed to the positions asse.